Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Morton Collins currently holds 120,000 shares of INOVIO PHARMACEUTICALS, INC. (INO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Morton Collins has been a net buyer of INO stock. They have purchased $2.1M and sold $2.0M worth of shares.
Morton Collins's most recent insider trade was on Dec 7, 2021, when they sold 20,000 shares at $5.05 per share.
Morton Collins serves as Executive at INOVIO PHARMACEUTICALS, INC. (INO). They have executed 73 insider transactions totaling $4.2M over their tenure at the company.
Morton Collins holds the position of Executive at INOVIO PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Morton Collins has shown a buying trading pattern, with $2.1M in total purchases and $2.0M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Morton Collins was on Feb 16, 2021, when they sold $565.1K worth of KOPN shares. This transaction involved 44,500 shares at $12.70 per share.
Morton Collins currently owns 120,000 shares of INOVIO PHARMACEUTICALS, INC. (INO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Morton Collins's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Morton Collins has 73 Form 4 filings on record as an insider at INOVIO PHARMACEUTICALS, INC..
Set alerts for Morton Collins and 40,000+ other insiders.